Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rutin sulfate is a semi-synthetic sulfated derivative of the flavonoid glycoside rutin, developed by Sichuan Lele Pharmaceutical Technology Development (also known as Sichuan Xieli Pharmaceutical). As a derivative of rutin, it is designed to enhance the water solubility and pharmacological profile of the parent molecule. Rutin sulfate is primarily investigated for its vasoprotective, anti-inflammatory, and antioxidant properties. It is typically positioned for the treatment of microvascular disorders, chronic venous insufficiency, and capillary fragility, where it acts to maintain vascular integrity and reduce permeability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rutin sulfate.